Alternatives to Flecainide If You Can't Fill Your Prescription

If your pharmacy is out of flecainide, you may be wondering whether you can simply switch to another heart rhythm medication. The short answer: possibly, but only with your cardiologist's guidance. Antiarrhythmic drugs have narrow therapeutic windows and serious potential risks. Never switch medications on your own.

That said, knowing what alternatives exist — and how they compare to flecainide — can help you have a more informed conversation with your doctor. Here's what to know about each option.

Why Flecainide Alternatives Require Careful Selection

Flecainide belongs to the Class IC antiarrhythmic family. It works by blocking fast sodium channels, slowing electrical conduction through the heart. This mechanism is highly effective for certain types of arrhythmias — but it's also dangerous in patients with structural heart disease (such as a history of heart attack, heart failure, or cardiomyopathy).

Any alternative must be matched not just to your arrhythmia type, but also to your heart anatomy, ejection fraction, kidney function, and other medications. This is why cardiologist oversight is non-negotiable.

Alternative 1: Propafenone (Rythmol, Rythmol SR)

Propafenone is the closest Class IC alternative to flecainide. Like flecainide, it blocks sodium channels and is approved for paroxysmal AFib and PSVT in patients without structural heart disease. It also has mild beta-blocking properties, which means it can help control heart rate as well as rhythm.

Key advantages: Available as immediate-release (3x/day) or extended-release Rythmol SR (2x/day); generally well-tolerated; outpatient initiation is possible in many cases.

Key limitations: Same structural heart disease contraindication as flecainide; the beta-blocking effect may not be desirable for all patients; some individuals metabolize it differently based on CYP2D6 enzyme status.

Best for: Patients with structurally normal hearts who can tolerate some heart rate slowing.

Alternative 2: Sotalol (Betapace, Sorine)

Sotalol is a Class III antiarrhythmic that also has significant beta-blocking properties. Unlike flecainide, sotalol can be used in patients with certain types of structural heart disease — making it a common alternative when flecainide is contraindicated or unavailable.

Key advantages: Can be used with some structural heart disease; also slows heart rate; widely available as a generic; can be used for both AFib and ventricular arrhythmias.

Key limitations: Requires in-hospital initiation with ECG monitoring (at least 3 days); risk of QT prolongation and torsade de pointes; requires dose adjustment for kidney disease; should not be stopped abruptly (beta-blocker rebound).

Best for: Patients with mild to moderate structural heart disease, especially if rate control is also needed.

Alternative 3: Dronedarone (Multaq)

Dronedarone is a Class III antiarrhythmic approved for paroxysmal or persistent atrial fibrillation and atrial flutter in patients without severe or recently decompensated heart failure. It was designed as a safer alternative to amiodarone with fewer long-term side effects.

Key advantages: Outpatient initiation is possible; lower risk of organ toxicity than amiodarone; also reduces stroke risk and cardiovascular hospitalization; twice-daily dosing.

Key limitations: Contraindicated in permanent AFib and in NYHA Class III–IV heart failure; can cause liver toxicity in rare cases; interaction with flecainide (cannot be used together); generally less effective than amiodarone.

Best for: Paroxysmal or persistent AFib patients without severe heart failure who want outpatient initiation.

Alternative 4: Amiodarone (Pacerone, Nexterone)

Amiodarone is the most effective antiarrhythmic drug currently available and works for a wide range of arrhythmias — including in patients with significant structural heart disease. It's typically reserved for patients who have failed other antiarrhythmics or have complex cardiac conditions.

Key advantages: Most effective at maintaining sinus rhythm; safe for use with structural heart disease, heart failure, and coronary artery disease; available as generic (Pacerone).

Key limitations: Requires long-term monitoring for serious organ toxicity: thyroid, lung (pulmonary toxicity), liver, eyes, and skin. It also has a very long half-life (40–55 days), meaning side effects can persist long after stopping the drug.

Best for: Patients with structural heart disease or those who have failed other antiarrhythmics.

Alternative 5: Dofetilide (Tikosyn)

Dofetilide is a Class III antiarrhythmic approved for AFib and atrial flutter. It is the only antiarrhythmic available exclusively through a REMS (Risk Evaluation and Mitigation Strategy) program, meaning prescribers must be trained and pharmacies must be certified to dispense it.

Key advantages: Can be used in patients with structural heart disease; effective for AFib cardioversion and maintenance of sinus rhythm.

Key limitations: Requires in-hospital initiation; REMS program limits prescribing to certified providers and dispensing to certified pharmacies; significant drug interactions; expensive without insurance.

Summary Comparison Table

Propafenone (Rythmol): Class IC | No structural heart disease | Outpatient start possible

Sotalol (Betapace): Class III + beta-blocker | Some structural disease OK | Hospital initiation required

Dronedarone (Multaq): Class III | No severe HF | Outpatient start possible

Amiodarone (Pacerone): Class III | Structural disease OK | Most effective; long-term monitoring required

Dofetilide (Tikosyn): Class III | Structural disease OK | REMS program; hospital initiation

What About Non-Drug Options?

For some patients, catheter ablation is an option worth discussing. It's a procedure that destroys the tissue responsible for triggering the arrhythmia. While it's not a substitute for an immediate medication need, it may reduce or eliminate the long-term need for antiarrhythmic drugs. Talk to your electrophysiologist about whether you're a candidate.

First Priority: Keep Looking for Flecainide

Before discussing a switch, it's worth exhausting your search options for flecainide itself. Availability gaps are usually localized and temporary. Read our guide to finding flecainide in stock — and consider using medfinder.com to check multiple pharmacies near you quickly.